Edition:
United Kingdom

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

16.10USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$16.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,429
52-wk High
$37.00
52-wk Low
$10.50

Chart for

About

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $166.71
Shares Outstanding(Mil.): 52.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Medicines Company Announces Definitive Agreement To Sell Its Infectious Disease Business Unit To Melinta Therapeutics

* THE MEDICINES COMPANY ANNOUNCES DEFINITIVE AGREEMENT TO SELL ITS INFECTIOUS DISEASE BUSINESS UNIT TO MELINTA THERAPEUTICS

29 Nov 2017

BRIEF-Melinta Therapeutics Enters Agreement To Acquire Infectious Disease Business From The Medicines Company

* MELINTA THERAPEUTICS ENTERS INTO AGREEMENT TO ACQUIRE INFECTIOUS DISEASE BUSINESS FROM THE MEDICINES COMPANY Source text for Eikon: Further company coverage:

29 Nov 2017

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,448 +16.50
Johnson & Johnson (JNJ.N) $142.46 --
Pfizer Inc. (PFE.N) $37.20 --
Roche Holding Ltd. (ROG.S) CHF244.70 +0.60
Roche Holding Ltd. (RO.S) CHF245.60 +2.20
Abbott Laboratories (ABT.N) $55.50 --
Bayer AG (BAYGn.DE) €108.00 +1.50
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.56 +1.01
AstraZeneca plc (AZN.L) 4,893.00 +12.00

Earnings vs. Estimates